Selected Publications
1) Harvey C*, Thimmulappa R*, Sethi S, Kong X, Yarmus L, Brown R, Feller-Kopman D, Wise R, and Biswal S. (2011) Targeting Nrf2 Signaling Improves Bacterial Clearance by Alveolar Macrophages in Patients with COPD and in a Mouse Model. Sci Transl Med 3(78):78ra32. PMID: 21490276 (*Contributed equally)
2) Kong X*, Thimmulappa R*, Kombairaju P, and Biswal S. (2010) NADPH Oxidase-Dependent Reactive Oxygen Species Mediate Amplified TLR4 Signaling and Sepsis-Induced Mortality in Nrf2-deficient Mice. J Immunol 185(1):569-77. PMID: 20511556 (*Contributed equally)
3. Yoshida T, Mett I, Bhunia A, Bowman J, Perez M, Zhang L, Gandjeva A, Zhen L, Chukwueke U, Mao T, Richter A, Brown E, Ashush H, Notkin N, Gelfand A, Thimmulappa R, Rangasamy T, Sussan T, Cosgrove G, Mouded M, Shapiro S, Petrache, Biswal S, Feinstein E, and Tuder R. (2010) RTP801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke induced pulmonary injury and emphysema. Nat Med 16(7):767-73. PMID: 20473305
4. Malhotra D*, Thimmulappa R*, Vij N, Sussan T, Merali S, Zhang L, Kelsen S, Myers A, Wise R, Tuder RM, and Biswal S. (2009) Heightened endoplasmic reticulum stress in COPD lungs: the role of Nrf2 regulated proteasomal activity. Am J Respir Crit Care Med. 180:1196-1207. PMID: 19797762 (*Contributed equally)
5. Sussan TE, Jun J, Thimmulappa R, Bedja D, Antero M, Gabrielson KL, Polotsky VY, Biswal S, Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice. PLoS ONE. 2008;3(11):e3791.
6. Singh A, Adamsky S, Thimmulappa RK, Rath S, Ashush A, Coulter J, Blackford A, Goodman S, Watson W, Bunz F, Gabrielson E, Feinstein E, Biswal S. RNAi mediated silencing of Nrf2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res, (2008) 68(19):7975-84.
7. Malhotra D*, Thimmulappa R*, Navas-Acien A., Sandford A, Elliot M, Singh A, Chen L, Zhuang X, Hogg J, Pare P, Tuder RM, Biswal S. Decline in Nrf2 regulated antioxidants in COPD lungs due to loss of its positive regulator DJ-1. Am. J. Respir. Crit. Care. Med. (2008) 178(6):592-604.
8. Thimmulappa, R.K, Fuchs R.J, Malhotra, D, Scollick, C., Trarore, K., Bream J.H, Trush M.A., Liby K.T., Spoorn, M., Kensler,T.W and Biswal,S., Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils. Antioxid Redox Signal (2007) 9:1963-70.
9. Anju Singh, Vikas Misra, Rajesh K. Thimmulappa, Hannah Lee, Stephen Ames, Mohammad O. Hoque, James G. Herman, Stephen B. Baylin, David Sidransky, Edward Gabrielson2, Malcolm Brock, Shyam Biswal, Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer. PLoS Med. (2006) 3(10) :1865-1876.
10. Rajesh K Thimmulappa, Hannah Lee, Tirumalai Rangasamy, Shekar Reddy, Thomas W. Kensler, Masayuki Yamamoto, and Shyam Biswal, Nrf2 is a critical regulator of innate immune response and survival during experimental sepsis. J Clin Invest. (2006) 116(4) :984-95.
11. Rangasamy T, Cho CY *, Rajesh K Thimmulappa *, Zhen L, Srisuma SS, Kensler TW, Yamamoto M, Petrache I, Tuder RM, Biswal S. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest. (2004) 114(9)1248-59. (* Contributed equally)
12. Rajesh K Thimmulappa, Kim Mai, S. Srisuma, Kensler, T.W., Yamamoto, M and SS Biswal, Identification of Nrf2 Regulated Genes by Oligonucleotide Microarray: Potential Role in Cancer Chemoprevention. Cancer Res. (2002) 62(18) 5196-203.